isoxazoles has been researched along with dicarbethoxydihydrocollidine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, K; Khosla, C; Kosek, JC; Omary, MB; Siegel, M; Strnad, P; Toivola, DM | 1 |
Houle, T; Hulubei, V; McKenna, JI; Meikrantz, SB; Natale, NR; Quincy, DA; Rogers, ME; Steiger, S | 1 |
2 other study(ies) available for isoxazoles and dicarbethoxydihydrocollidine
Article | Year |
---|---|
Pharmacologic transglutaminase inhibition attenuates drug-primed liver hypertrophy but not Mallory body formation.
Topics: Animals; Cell Size; Chemical and Drug Induced Liver Injury; Dicarbethoxydihydrocollidine; Enzyme Inhibitors; GTP-Binding Proteins; Hepatomegaly; Humans; Inclusion Bodies; Isoxazoles; Keratins; Liver Diseases; Mice; Mice, Inbred C3H; Protein Glutamine gamma Glutamyltransferase 2; Proteins; Transglutaminases | 2006 |
4-Isoxazolyl-1,4-dihydropyridines exhibit binding at the multidrug-resistance transporter.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Calcium Channels; Dicarbethoxydihydrocollidine; Dihydropyridines; Humans; Isoxazoles; Magnetic Resonance Spectroscopy; Models, Chemical; Protein Binding; Structure-Activity Relationship; Thermodynamics | 2012 |